PSIL — AdvisorShares Psychedelics ETF
Data updated: 2026-08-21
PSIL — AdvisorShares Psychedelics ETF. Global (incl. US) Small Cap Growth Materials Equity · $44.43M AUM. Holdings, fees, performance and SEC filings.
PSIL Fund Overview
PSIL — AdvisorShares Psychedelics ETF is a US ETF managed by AdvisorShares Trust, categorised as Global (incl. US) Small Cap Growth Materials Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: AdvisorShares Trust
- Category: Global (incl. US) Small Cap Growth Materials Equity
- Assets under management: $44.43M
- 1-year return: 88.4%
- Ticker: PSIL
- SEC CIK: 0001408970
- SEC series ID: S000072085
- Share class ID: C000227806
PSIL Holdings
Top 10 holdings of AdvisorShares Psychedelics ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Definium Therapeutics, Inc. | 12.85% |
| Compass Pathways PLC | 11.45% |
| Ataibeckley, Inc. | 10.47% |
| Relmada Therapeutics, Inc. | 6.84% |
| Nrx Pharmaceuticals, Inc. | 6.07% |
| Neurocrine Biosciences, Inc. | 4.38% |
| Cybin, Inc. | 4.35% |
| Gh Research PLC | 4.31% |
| Alkermes PLC | 4.30% |
| Alto Neuroscience, Inc. | 4.20% |
PSIL Portfolio Allocation
Asset-class allocation of AdvisorShares Psychedelics ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 95.9% |
| Cash & Equivalents | 7.1% |
PSIL Performance
Total returns for PSIL (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 37.2% |
| 1 year | 88.4% |
| 3 years (annualised) | 13.5% |
PSIL Risk Information
Risk metrics for PSIL, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 25.7%
PSIL Costs and Fees
PSIL costs about $100 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.00%
- Gross expense ratio: 1.84%
- Portfolio turnover: 107%
- Brokerage commissions: 207.78 bps of average net assets (SEC N-CEN)
PSIL Cashflows
Over the 12 months to 2026-06, AdvisorShares Psychedelics ETF had net inflows of $22.26M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $4.08M |
| 2026-05 | $1.22M |
| 2026-04 | $9.15M |
| 2026-03 | $0 |
| 2026-02 | $0 |
| 2026-01 | $1.98M |
PSIL Debt Constituents
No individual debt constituents are reported in AdvisorShares Psychedelics ETF's latest SEC N-PORT filing.
PSIL Prospectus and SEC Filings
Official AdvisorShares Psychedelics ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-10-28
- Prospectus (485BPOS) — filed 2024-10-29
- Prospectus (485BPOS) — filed 2023-10-30
- Portfolio holdings (N-PORT) — filed 2026-08-21
- Portfolio holdings (N-PORT) — filed 2026-05-21
- Portfolio holdings (N-PORT) — filed 2026-02-23
- Annual census (N-CEN) — filed 2025-09-09
- Annual census (N-CEN) — filed 2024-09-11
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.